1-4 of 4
Robin Harrelson
Close
Save search
Sort by
Journal Articles

The Mitochondrial Metabolism Inhibitor Cpi-613 Is Highly Active in Combination with High Dose Ara-C (HiDAC) and Mitoxantrone in a Phase I Study for Relapsed or Refractory Acute Myeloid Leukemia (AML)

Free
Timothy S Pardee, MD PhD, Kristin Stadelman, MS, Scott Isom, MS, Leslie Renee Ellis, MD, Dmitriy Berenzon, MD, David D Hurd, MD, Robin Harrelson, BSN, Megan Manuel, MSN, Sarah Dralle, MSN, Susan Lyerly, PA, Bayard L. Powell, MD
Journal: Blood
Blood (2014) 124 (21): 3744.
https://doi.org/10.1182/blood.V124.21.3744.3744
Published: 2014
Journal Articles

A Phase I Study Of The Safety, Efficacy and Pharmacokinetics Of The First In Class Pyruvate Dehydrogenase Complex Inhibitor Cpi-613 In Patients With Advanced Hematologic Malignancies

Free
Timothy Pardee, MD, PhD, King Lee, PhD, RAC, John Luddy, MS, Claudia Maturo, MS, Robert Rodriguez, BSc, MBA, Denise A Levitan, MD, David D Hurd, MD, Leslie Renee Ellis, MD, Scott Isom, MS, Robin Harrelson, BSN, Megan Manuel, MSN, Sarah Dralle, MSN, Susan Lyerly, PA, Bayard L. Powell, MD
Journal: Blood
Blood (2013) 122 (21): 486.
https://doi.org/10.1182/blood.V122.21.486.486
Published: 2013
Journal Articles

High Dose Cytarabine and Clofarabine (HiDAC → CLOF) in Relapsed or Refractory Acute Myeloid Leukemia, a Phase 2 Trial.

Free
Bayard Powell, Ralph D’Agostino, Jr., PhD, Denise Levitan, MD, Leslie Renee Ellis, MD, Susan Lyerly, PA-C, Megan Skiles, PA-C, Megan Manuel, NP, Robin Harrelson, RN, Claire Kimbrough, David Duane Hurd, MD
Journal: Blood
Blood (2008) 112 (11): 1936.
https://doi.org/10.1182/blood.V112.11.1936.1936
Published: 2008
Journal Articles

Limited Phase I Trial of Sequential High Dose Cytarabine and Clofarabine (HiDAC→CLOF) in Relapsed or Refractory Acute Myeloid Leukemia.

Free
Bayard L. Powell, MD, James Lovato, PhD, Claire Kimbrough, Susan Lyerly, PA-C, Sonya Galloway-Daniels, NP, Cathy Motley, RN, Robin Harrelson, RN, Yi Kong Keung, MD, Mohan C. Thakuri, MD, Istvan Molnar, MD, Denise Levitan, MD, David Duane Hurd, MD
Journal: Blood
Blood (2006) 108 (11): 4565.
https://doi.org/10.1182/blood.V108.11.4565.4565
Published: 2006